The Purpose of this conference is to provide attendees with access to cutting edge clinical and basic science research in the fields of clinical nephrology and transplantation, renal physiology and pharmacology, and renal pathology and immunology.
- Physicians
- Physicians Assistants
- Nurse/Nurse Practitioners
- Medical Students
At the conclusion of this activity, I will be able to:
1. Kearn how suPAR is causinf kidney disease
2. Learn how to better assess renal function
3. Understand molecular signaling pathways to treat renal disease moe effectively
Name | Company | Role |
Jochen Reiser, MD, PhD | TRISAQ | Co-Founder of TRISAQ Company |
Jochen Reiser, MD, PhD | Massachusetts General Hospital | Consultant |
In accordance with the ACCME® Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.
Contact
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.